To circumvent the pitfalls imposed by the overexpression of recombinant TRPM7, we took advantage of human haploid leukemia (HAP1) cells that lack endogenous TRPM7 currents due to a frameshift mutation introduced in the TRPM7 locus (13). The gene discussed is TRPM7; the disease is leukemia.